- Obesity drug achieves average weight loss of 24 kg in clinical trial | New Scientist https://www.newscientist.com/article/2318588-obesity-drug-achieves-average-weight-loss-of-24-kg-in-clinical-trial/ 47 comments science
Linking pages
Linked pages
- https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-delivered-225-weight-loss-adults-obesity-or 179 comments
- Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 73 comments
- Inhaled powder that coats airways can block coronavirus infection | New Scientist https://www.newscientist.com/article/2358783-inhaled-powder-that-coats-airways-can-block-coronavirus-infection/ 1 comment
- FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 0 comments
Related searches:
Search whole site: site:www.newscientist.com
Search title: Obesity drug achieves average weight loss of 24 kg in clinical trial | New Scientist
See how to search.